-
1
-
-
33847278423
-
Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae)
-
10.1016/j.phytochem.2006.11.029
-
AM Brinier J Ma PE Lipsky I Raskin 2007 Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae) Phytochemistry 68 6 732 766 10.1016/j.phytochem.2006.11.029
-
(2007)
Phytochemistry
, vol.68
, Issue.6
, pp. 732-766
-
-
Brinier, A.M.1
Ma, J.2
Lipsky, P.E.3
Raskin, I.4
-
2
-
-
0030939874
-
A potential new treatment for rheumatoid arthritis: Thunder god vine
-
10.1016/S0049-0172(97)80040-6 1:STN:280:DyaK2s3ptVSlsQ%3D%3D 9144848
-
PE Lipsky XL Tao 1997 A potential new treatment for rheumatoid arthritis: thunder god vine Semin Arthritis Rheum 26 5 713 723 10.1016/S0049-0172(97) 80040-6 1:STN:280:DyaK2s3ptVSlsQ%3D%3D 9144848
-
(1997)
Semin Arthritis Rheum
, vol.26
, Issue.5
, pp. 713-723
-
-
Lipsky, P.E.1
Tao, X.L.2
-
3
-
-
77956189861
-
Lei gong teng zai feng shi xing ji bing zhong de ying yong gai shu
-
X Zhang Z Chi 2004 Lei gong teng zai feng shi xing ji bing zhong de ying yong gai shu Henan Tad Chin Med 24 3 80 82
-
(2004)
Henan Tad Chin Med
, vol.24
, Issue.3
, pp. 80-82
-
-
Zhang, X.1
Chi, Z.2
-
4
-
-
33747102122
-
A systematic review of randomised clinical trials of Tripterygium wilfordii for rheumatoid arthritis
-
10.1016/j.phymed.2006.01.010 1:CAS:528:DC%2BD28XmtFKks7s%3D 16487688
-
PH Canter HS Lee E Ernst 2006 A systematic review of randomised clinical trials of Tripterygium wilfordii for rheumatoid arthritis Phytomedicine 13 5 371 377 10.1016/j.phymed.2006.01.010 1:CAS:528:DC%2BD28XmtFKks7s%3D 16487688
-
(2006)
Phytomedicine
, vol.13
, Issue.5
, pp. 371-377
-
-
Canter, P.H.1
Lee, H.S.2
Ernst, E.3
-
5
-
-
69149101082
-
Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: A randomized trial
-
19687490
-
R Goldbach-Mansky M Wilson R Fleischmann N Olsen J Silverfield P Kempf, et al. 2009 Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial Ann Intern Med 151 4 229 240 19687490
-
(2009)
Ann Intern Med
, vol.151
, Issue.4
, pp. 229-240
-
-
Goldbach-Mansky, R.1
Wilson, M.2
Fleischmann, R.3
Olsen, N.4
Silverfield, J.5
Kempf, P.6
-
6
-
-
0036065039
-
Benefit of an extract of Tripterygium wilfordii Hook F in patients with rheumatoid arthritis: A double-blind, placebo-controlled study
-
10.1002/art.10411 12124856
-
X Tao J Younger FZ Fan B Wang PE Lipsky 2002 Benefit of an extract of Tripterygium wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study Arthritis Rheum 46 7 1735 1743 10.1002/art.10411 12124856
-
(2002)
Arthritis Rheum
, vol.46
, Issue.7
, pp. 1735-1743
-
-
Tao, X.1
Younger, J.2
Fan, F.Z.3
Wang, B.4
Lipsky, P.E.5
-
7
-
-
0023368234
-
A double-blind study of T2 (tablets of polyglycosides of Tripterygium wilfordii Hook) in the treatment of rheumatoid arthritis
-
1:STN:280:DyaL1c7htVyhsg%3D%3D 3322706
-
XL Tao Y Dong NZ Zhang 1987 A double-blind study of T2 (tablets of polyglycosides of Tripterygium wilfordii Hook) in the treatment of rheumatoid arthritis Zhonghua Nei Ke Za Zhi 26 399 402 1:STN:280:DyaL1c7htVyhsg%3D%3D 3322706
-
(1987)
Zhonghua Nei Ke Za Zhi
, vol.26
, pp. 399-402
-
-
Tao, X.L.1
Dong, Y.2
Zhang, N.Z.3
-
8
-
-
0019374043
-
Tripterygium wilfordii Hook f in rheumatoid arthritis and ankylosing spondylitis. Preliminary report
-
1:STN:280:DyaL38%2FntFKlug%3D%3D 6796344
-
J Guo S Yuan X Wang S Xu D Li 1981 Tripterygium wilfordii Hook f in rheumatoid arthritis and ankylosing spondylitis. Preliminary report Chin Med J 94 7 405 412 1:STN:280:DyaL38%2FntFKlug%3D%3D 6796344
-
(1981)
Chin Med J
, vol.94
, Issue.7
, pp. 405-412
-
-
Guo, J.1
Yuan, S.2
Wang, X.3
Xu, S.4
Li, D.5
-
9
-
-
33744910087
-
Concepts and epidemiology of spondyloarthritis
-
10.1016/j.berh.2006.02.001 16777573
-
J Sieper M Rudwaleit MA Khan J Braun 2006 Concepts and epidemiology of spondyloarthritis Best Pract Res Clin Rheumatol 20 3 401 417 10.1016/j.berh.2006.02.001 16777573
-
(2006)
Best Pract Res Clin Rheumatol
, vol.20
, Issue.3
, pp. 401-417
-
-
Sieper, J.1
Rudwaleit, M.2
Khan, M.A.3
Braun, J.4
-
10
-
-
47049108175
-
Assessment and treatment of ankylosing spondylitis: Current status and future directions
-
10.1097/BOR.0b013e3283028328 18525351
-
J Zochling 2008 Assessment and treatment of ankylosing spondylitis: current status and future directions Curr Opin Rheumatol 20 4 398 403 10.1097/BOR.0b013e3283028328 18525351
-
(2008)
Curr Opin Rheumatol
, vol.20
, Issue.4
, pp. 398-403
-
-
Zochling, J.1
-
11
-
-
0021272107
-
Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria
-
10.1002/art.1780270401 6231933
-
S van der Linden HA Valkenburg A Cats 1984 Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria Arthritis Rheum 27 4 361 368 10.1002/art.1780270401 6231933
-
(1984)
Arthritis Rheum
, vol.27
, Issue.4
, pp. 361-368
-
-
Van Der Linden, S.1
Valkenburg, H.A.2
Cats, A.3
-
12
-
-
56449115890
-
Tumor necrosis factor-alpha blockade leads to decreased peripheral T cell reactivity and increased dendritic cell number in peripheral blood of patients with ankylosing spondylitis
-
10.3899/jrheum.080219 1:CAS:528:DC%2BD1cXhsVKmtrnJ 19004053
-
L Pang L Wang T Suo H Hao X Fang J Jia, et al. 2008 Tumor necrosis factor-alpha blockade leads to decreased peripheral T cell reactivity and increased dendritic cell number in peripheral blood of patients with ankylosing spondylitis J Rheumatol 35 11 2220 2228 10.3899/jrheum.080219 1:CAS:528:DC%2BD1cXhsVKmtrnJ 19004053
-
(2008)
J Rheumatol
, vol.35
, Issue.11
, pp. 2220-2228
-
-
Pang, L.1
Wang, L.2
Suo, T.3
Hao, H.4
Fang, X.5
Jia, J.6
-
13
-
-
0028579768
-
A new approach to defining functional ability in ankylosing spondylitis: The development of the bath ankylosing spondylitis functional index
-
1:STN:280:DyaK2M3htl2qsA%3D%3D 7699629
-
A Calin S Garrett H Whitelock LG Kennedy J O'Hea P Mallorie, et al. 1994 A new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index J Rheumatol 21 12 2281 2285 1:STN:280:DyaK2M3htl2qsA%3D%3D 7699629
-
(1994)
J Rheumatol
, vol.21
, Issue.12
, pp. 2281-2285
-
-
Calin, A.1
Garrett, S.2
Whitelock, H.3
Kennedy, L.G.4
O'Hea, J.5
Mallorie, P.6
-
14
-
-
0028575453
-
A new approach to defining disease status in ankylosing spondylitis: The bath ankylosing spondylitis disease activity index
-
1:STN:280:DyaK2M3htl2qsQ%3D%3D 7699630
-
S Garrett T Jenkinson LG Kennedy H Whitelock P Gaisford A Calin 1994 A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index J Rheumatol 21 12 2286 2291 1:STN:280:DyaK2M3htl2qsQ%3D%3D 7699630
-
(1994)
J Rheumatol
, vol.21
, Issue.12
, pp. 2286-2291
-
-
Garrett, S.1
Jenkinson, T.2
Kennedy, L.G.3
Whitelock, H.4
Gaisford, P.5
Calin, A.6
-
15
-
-
0028129277
-
Defining spinal mobility in ankylosing spondylitis (AS). The bath as metrology index
-
1:STN:280:DyaK2M%2Fpslaquw%3D%3D 7799351
-
TR Jenkinson PA Mallorie HC Whitelock LG Kennedy SL Garrett A Calin 1994 Defining spinal mobility in ankylosing spondylitis (AS). The bath as metrology index J Rheumatol 21 9 1694 1698 1:STN:280:DyaK2M%2Fpslaquw%3D%3D 7799351
-
(1994)
J Rheumatol
, vol.21
, Issue.9
, pp. 1694-1698
-
-
Jenkinson, T.R.1
Mallorie, P.A.2
Whitelock, H.C.3
Kennedy, L.G.4
Garrett, S.L.5
Calin, A.6
-
16
-
-
0029969624
-
The bath ankylosing spondylitis patient global score (BAS-G)
-
10.1093/rheumatology/35.1.66 1:STN:280:DyaK283gt1Kiug%3D%3D 8624626
-
SD Jones A Steiner SL Garrett A Calin 1996 The bath ankylosing spondylitis patient global score (BAS-G) Br J Rheumatol 35 1 66 71 10.1093/rheumatology/35.1.66 1:STN:280:DyaK283gt1Kiug%3D%3D 8624626
-
(1996)
Br J Rheumatol
, vol.35
, Issue.1
, pp. 66-71
-
-
Jones, S.D.1
Steiner, A.2
Garrett, S.L.3
Calin, A.4
-
17
-
-
0034888069
-
Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis
-
10.1002/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F 1:STN:280:DC%2BD3MvmtlGntw%3D%3D 11508441
-
JJ Anderson G Baron D van der Heijde DT Felson M Dougados 2001 Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis Arthritis Rheum 44 8 1876 1886 10.1002/1529- 0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F 1:STN:280: DC%2BD3MvmtlGntw%3D%3D 11508441
-
(2001)
Arthritis Rheum
, vol.44
, Issue.8
, pp. 1876-1886
-
-
Anderson, J.J.1
Baron, G.2
Van Der Heijde, D.3
Felson, D.T.4
Dougados, M.5
-
18
-
-
84997349315
-
The adverse reaction of lei gong teng
-
T Wan 2005 The adverse reaction of lei gong teng Pract Clin Med 6 149 150
-
(2005)
Pract Clin Med
, vol.6
, pp. 149-150
-
-
Wan, T.1
-
19
-
-
55849108826
-
Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double-blind, placebo-controlled, phase III trial
-
10.1002/art.23969 1:CAS:528:DC%2BD1cXhsV2hs7nL 18975305
-
RD Inman JC Davis Jr DV Heijde L Diekman J Sieper SI Kim, et al. 2008 Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial Arthritis Rheum 58 11 3402 3412 10.1002/art.23969 1:CAS:528:DC%2BD1cXhsV2hs7nL 18975305
-
(2008)
Arthritis Rheum
, vol.58
, Issue.11
, pp. 3402-3412
-
-
Inman, R.D.1
Davis Jr., J.C.2
Heijde, D.V.3
Diekman, L.4
Sieper, J.5
Kim, S.I.6
-
20
-
-
13444253765
-
Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo-controlled trial (ASSERT)
-
10.1002/art.20852 15692973
-
D van der Heijde B Dijkmans P Geusens J Sieper K DeWoody P Williamson, et al. 2005 Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT) Arthritis Rheum 52 2 582 591 10.1002/art.20852 15692973
-
(2005)
Arthritis Rheum
, vol.52
, Issue.2
, pp. 582-591
-
-
Van Der Heijde, D.1
Dijkmans, B.2
Geusens, P.3
Sieper, J.4
Dewoody, K.5
Williamson, P.6
-
21
-
-
67449116868
-
Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: Long-term results from the ATLAS trial
-
van der Heijde D, Schiff MH, Sieper J, Kivitz A, Wong RL, Kupper H, et al (2008) Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial. Ann Rheum Dis
-
(2008)
Ann Rheum Dis
-
-
Van Der Heijde, D.1
Schiff, M.H.2
Sieper, J.3
Kivitz, A.4
Wong, R.L.5
Kupper, H.6
-
22
-
-
33750700344
-
The adverse reaction of lei gong teng application in dermatology
-
Y Tang X Zhang B Su 1998 The adverse reaction of lei gong teng application in dermatology J Clin Dermatol 27 377
-
(1998)
J Clin Dermatol
, vol.27
, pp. 377
-
-
Tang, Y.1
Zhang, X.2
Su, B.3
|